DQ Overview

Market Overview: The stock market is experiencing turbulence, with the Nasdaq down 2.74% and a notable rotation into healthcare, which is currently the only sector showing strong opportunities. The crypto market is facing significant challenges, indicating a critical juncture ahead.

Dianthus Therapeutics: Dianthus Therapeutics (DNTH) is a clinical-stage biotech company focused on innovative therapies for autoimmune diseases, showing potential for a 95% return. Despite a high Price-to-Sales ratio, recent technical patterns suggest an upward momentum.

Daqo New Energy: Daqo New Energy (DQ), a leading polysilicon manufacturer for solar products, presents a 78% return potential. The company is well-positioned to benefit from the growing renewable energy sector, with strong operational resilience and strategic expansion plans.

Arcus Biosciences: Arcus Biosciences (RCUS) is developing advanced cancer therapies, with a 45% return potential. The company is backed by significant partnerships and funding, allowing it to aggressively pursue its pipeline while navigating the biotech landscape.

Annual General Meeting Announcement: Daqo New Energy Corp. will hold its annual general meeting on December 12, 2025, at its Shanghai office, with eligible shareholders invited to attend.

Eligibility for Attendance: Shareholders of record as of November 28, 2025, will be entitled to attend the AGM in person, and they can request a hard copy of the annual report.

Company Overview: Daqo New Energy Corp. is a leading manufacturer of high-purity polysilicon for the solar PV industry, with a nameplate capacity of 305,000 metric tons and recognized as one of the lowest cost producers.

Contact Information: Shareholders can obtain more information or request documents through the company's website or by contacting the Investor Relations Department directly.

U.S. Stock Futures: U.S. stock futures are up, with Nasdaq futures increasing by about 100 points on Wednesday morning.

FLEX LNG Earnings Report: FLEX LNG Ltd shares dropped 8.4% in pre-market trading after reporting quarterly earnings of 43 cents per share, missing the analyst estimate of 46 cents, despite beating sales expectations.

Other Stocks Declining: Several other stocks also saw declines in pre-market trading, including Biohaven Ltd (-7.7%), Samsara Inc (-7.4%), and Dingdong (Cayman) Ltd (-5.1%).

Market Overview: The overall market sentiment appears mixed, with some companies experiencing significant drops following earnings reports and offerings.